Ziyaad Waja to Mycobacterium tuberculosis
This is a "connection" page, showing publications Ziyaad Waja has written about Mycobacterium tuberculosis.
Connection Strength
1,195
-
The performance of tongue swabs for detection of pulmonary tuberculosis. Front Cell Infect Microbiol. 2023; 13:1186191.
Score: 0,168
-
SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen. Trials. 2023 Jun 28; 24(1):435.
Score: 0,166
-
Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response. Front Cell Infect Microbiol. 2022; 12:1064148.
Score: 0,160
-
Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV. BMC Infect Dis. 2021 May 22; 21(1):466.
Score: 0,143
-
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 05 06; 384(18):1705-1718.
Score: 0,143
-
Detection of differentially culturable tubercle bacteria in sputum using mycobacterial culture filtrates. Sci Rep. 2021 03 22; 11(1):6493.
Score: 0,142
-
Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppression. Tuberculosis (Edinb). 2021 01; 126:102023.
Score: 0,138
-
Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting. J Mol Diagn. 2020 10; 22(10):1225-1237.
Score: 0,135